• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制胶束胆汁酸的微生物去结合作用可预防肠道通透性和肝损伤。

Inhibition of microbial deconjugation of micellar bile acids protects against intestinal permeability and liver injury.

机构信息

Liver Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.

出版信息

Sci Adv. 2022 Aug 26;8(34):eabo2794. doi: 10.1126/sciadv.abo2794.

DOI:10.1126/sciadv.abo2794
PMID:36026454
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9417178/
Abstract

Altered host-microbe interactions and increased intestinal permeability have been implicated in disease pathogenesis. However, the mechanisms by which intestinal microbes affect epithelial barrier integrity remain unclear. Here, we investigate the impact of bacterial metabolism of host-produced bile acid (BA) metabolites on epithelial barrier integrity. We observe that rats fed a choline-deficient, l-amino acid-defined, high-fat diet (CDAHFD) exhibit reduced intestinal abundance of host-produced conjugated BAs at early time points, coinciding with increased gut permeability. We show that in vitro, conjugated BAs protect gut epithelial monolayers from damage caused by bacterially produced unconjugated BAs through micelle formation. We then demonstrate that inhibition of bacterial BA deconjugation with a small-molecule inhibitor prevents the development of pathologic intestinal permeability and hepatic inflammation in CDAHFD-fed rats. Our study identifies a signaling-independent, physicochemical mechanism for conjugated BA-mediated protection of epithelial barrier function and suggests that rational manipulation of microbial BA metabolism could be leveraged to regulate gut barrier integrity.

摘要

宿主-微生物相互作用的改变和肠道通透性的增加与疾病的发病机制有关。然而,肠道微生物影响上皮屏障完整性的机制尚不清楚。在这里,我们研究了细菌对宿主产生的胆汁酸(BA)代谢物的代谢作用对上皮屏障完整性的影响。我们观察到,给予胆碱缺乏、l-氨基酸定义的高脂肪饮食(CDAHFD)的大鼠在早期时间点表现出肠道中宿主产生的结合型 BA 丰度降低,同时肠道通透性增加。我们表明,在体外,结合型 BA 通过胶束形成保护肠道上皮单层免受细菌产生的未结合型 BA 引起的损伤。然后,我们证明用小分子抑制剂抑制细菌 BA 去结合可防止 CDAHFD 喂养的大鼠发生病理性肠道通透性和肝炎症。我们的研究确定了一种信号非依赖的、物理化学机制,用于结合型 BA 介导的上皮屏障功能保护,并表明合理操纵微生物 BA 代谢可以用来调节肠道屏障完整性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b6/9417178/2604694d7efe/sciadv.abo2794-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b6/9417178/f97994496fe1/sciadv.abo2794-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b6/9417178/c1b2975cb36b/sciadv.abo2794-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b6/9417178/bdd5ccb57b4f/sciadv.abo2794-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b6/9417178/6c5a076bceda/sciadv.abo2794-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b6/9417178/aa27f02e5a90/sciadv.abo2794-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b6/9417178/2604694d7efe/sciadv.abo2794-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b6/9417178/f97994496fe1/sciadv.abo2794-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b6/9417178/c1b2975cb36b/sciadv.abo2794-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b6/9417178/bdd5ccb57b4f/sciadv.abo2794-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b6/9417178/6c5a076bceda/sciadv.abo2794-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b6/9417178/aa27f02e5a90/sciadv.abo2794-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b6/9417178/2604694d7efe/sciadv.abo2794-f6.jpg

相似文献

1
Inhibition of microbial deconjugation of micellar bile acids protects against intestinal permeability and liver injury.抑制胶束胆汁酸的微生物去结合作用可预防肠道通透性和肝损伤。
Sci Adv. 2022 Aug 26;8(34):eabo2794. doi: 10.1126/sciadv.abo2794.
2
Western diet-induced increase in colonic bile acids compromises epithelial barrier in nonalcoholic steatohepatitis.西方饮食诱导结肠胆汁酸增加会损害非酒精性脂肪性肝炎的肠上皮屏障。
FASEB J. 2020 May;34(5):7089-7102. doi: 10.1096/fj.201902687R. Epub 2020 Apr 10.
3
Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice.胆汁酸是一个重要的宿主因素,可塑造饮食诱导肥胖小鼠的肠道微生物组。
BMC Biol. 2017 Dec 14;15(1):120. doi: 10.1186/s12915-017-0462-7.
4
High-grain diet feeding alters ileal microbiota and disrupts bile acid metabolism in lactating dairy cows.高谷物日粮喂养改变了哺乳期奶牛的回肠微生物群,并扰乱了胆汁酸代谢。
J Anim Sci. 2023 Jan 3;101. doi: 10.1093/jas/skad278.
5
Impact of Gut Microbiota-Mediated Bile Acid Metabolism on the Solubilization Capacity of Bile Salt Micelles and Drug Solubility.肠道微生物群介导的胆汁酸代谢对胆盐微团溶解能力及药物溶解度的影响
Mol Pharm. 2017 Apr 3;14(4):1251-1263. doi: 10.1021/acs.molpharmaceut.6b01155. Epub 2017 Feb 24.
6
Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.小分子抑制肠道微生物胆碱三甲基胺裂解酶活性改变宿主胆固醇和胆汁酸代谢。
Am J Physiol Heart Circ Physiol. 2020 Jun 1;318(6):H1474-H1486. doi: 10.1152/ajpheart.00584.2019. Epub 2020 Apr 24.
7
Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.FXR-FGF19 信号失调和胆碱代谢与儿科 NASH 新型猪模型中的肠道菌群失调和增生有关。
Am J Physiol Gastrointest Liver Physiol. 2020 Mar 1;318(3):G582-G609. doi: 10.1152/ajpgi.00344.2019. Epub 2020 Jan 31.
8
Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice.肠道微生物群相关的胆汁酸去结合作用加速ob/ob小鼠的肝脂肪变性。
J Appl Microbiol. 2016 Sep;121(3):800-10. doi: 10.1111/jam.13158. Epub 2016 Jul 29.
9
A High-Fat, High-Cholesterol Diet Promotes Intestinal Inflammation by Exacerbating Gut Microbiome Dysbiosis and Bile Acid Disorders in Cholecystectomy.高脂肪、高胆固醇饮食通过加剧胆囊切除术后肠道微生物组失调和胆汁酸紊乱促进肠道炎症。
Nutrients. 2023 Sep 1;15(17):3829. doi: 10.3390/nu15173829.
10
Fasting and refeeding triggers specific changes in bile acid profiles and gut microbiota.禁食和再喂养会引发胆汁酸谱和肠道微生物群的特定变化。
J Diabetes. 2023 Feb;15(2):165-180. doi: 10.1111/1753-0407.13356. Epub 2023 Jan 22.

引用本文的文献

1
Integrative network pharmacology, metabolomics and gut flora studies reveal mechanisms of action of (Blume) G. Don to ameliorate liver injury.整合网络药理学、代谢组学和肠道菌群研究揭示了(Blume)G. Don改善肝损伤的作用机制。
Front Microbiol. 2025 Sep 1;16:1570229. doi: 10.3389/fmicb.2025.1570229. eCollection 2025.
2
Crosstalk Between Microbiome and Ferroptosis in Diseases: From Mechanism to Therapy.疾病中微生物群与铁死亡之间的相互作用:从机制到治疗
Compr Physiol. 2025 Aug;15(4):e70042. doi: 10.1002/cph4.70042.
3
Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut-Liver Axis and Epiregulin-IL-8-Associated Angiogenesis.

本文引用的文献

1
A Gut-Restricted Lithocholic Acid Analog as an Inhibitor of Gut Bacterial Bile Salt Hydrolases.一种肠道限制的胆酸类似物,作为肠道细菌胆汁盐水解酶的抑制剂。
ACS Chem Biol. 2021 Aug 20;16(8):1401-1412. doi: 10.1021/acschembio.1c00192. Epub 2021 Jul 19.
2
Bile Acids, Their Receptors, and the Gut Microbiota.胆汁酸、其受体和肠道微生物群。
Physiology (Bethesda). 2021 Jul 1;36(4):235-245. doi: 10.1152/physiol.00028.2020.
3
Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability.
利福昔明通过抑制肠-肝轴和埃匹瑞肽-IL-8相关血管生成减轻大鼠MASH模型中的肝纤维化和肝癌发生。
Int J Mol Sci. 2025 Jul 12;26(14):6710. doi: 10.3390/ijms26146710.
4
BAAT away liver cancer: conjugated bile acids impair T cell function in hepatocellular carcinoma immunotherapy.BAAT可对抗肝癌:结合型胆汁酸损害肝细胞癌免疫治疗中的T细胞功能。
Immunometabolism (Cobham). 2025 May 9;7(2):e00062. doi: 10.1097/IN9.0000000000000062. eCollection 2025 Apr.
5
Balance between bile acid conjugation and hydrolysis activity can alter outcomes of gut inflammation.胆汁酸结合与水解活性之间的平衡会改变肠道炎症的结果。
Nat Commun. 2025 Apr 11;16(1):3434. doi: 10.1038/s41467-025-58649-x.
6
New insights into microbial bile salt hydrolases: from physiological roles to potential applications.微生物胆汁盐水解酶的新见解:从生理作用到潜在应用
Front Microbiol. 2025 Feb 12;16:1513541. doi: 10.3389/fmicb.2025.1513541. eCollection 2025.
7
Phytic acid-based nanomedicine against mTOR represses lipogenesis and immune response for metabolic dysfunction-associated steatohepatitis therapy.基于植酸的纳米药物靶向mTOR可抑制脂肪生成和免疫反应,用于治疗代谢功能障碍相关脂肪性肝炎。
Life Metab. 2024 Jun 18;3(6):loae026. doi: 10.1093/lifemeta/loae026. eCollection 2024 Dec.
8
Gut microbiota-mediated gut-liver axis: a breakthrough point for understanding and treating liver cancer.肠道微生物群介导的肠-肝轴:理解和治疗肝癌的突破点。
Clin Mol Hepatol. 2025 Apr;31(2):350-381. doi: 10.3350/cmh.2024.0857. Epub 2024 Dec 11.
9
Intestinal flora and bile acid interactions impact the progression of diabetic kidney disease.肠道菌群与胆汁酸相互作用影响糖尿病肾病的进展。
Front Endocrinol (Lausanne). 2024 Sep 20;15:1441415. doi: 10.3389/fendo.2024.1441415. eCollection 2024.
10
Structural and functional analysis of a bile salt hydrolase from the bison microbiome.从野牛微生物群中分析胆盐水解酶的结构和功能。
J Biol Chem. 2024 Oct;300(10):107769. doi: 10.1016/j.jbc.2024.107769. Epub 2024 Sep 12.
禁食和进食状态下的人十二指肠液:特征描述、药物溶解度,以及与模拟液和人体生物利用度的比较。
Eur J Pharm Biopharm. 2021 Jun;163:240-251. doi: 10.1016/j.ejpb.2021.04.005. Epub 2021 Apr 16.
4
Impaired Intestinal Barrier and Tissue Bacteria: Pathomechanisms for Metabolic Diseases.肠道屏障和组织细菌受损:代谢性疾病的发病机制。
Front Endocrinol (Lausanne). 2021 Mar 9;12:616506. doi: 10.3389/fendo.2021.616506. eCollection 2021.
5
A microbial metabolite remodels the gut-liver axis following bariatric surgery.减重手术后,一种微生物代谢产物重塑了肠道-肝脏轴。
Cell Host Microbe. 2021 Mar 10;29(3):408-424.e7. doi: 10.1016/j.chom.2020.12.004. Epub 2021 Jan 11.
6
Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression.胆汁酸谱、组织病理学指标和非酒精性脂肪性肝病进展的遗传变异。
Metabolism. 2021 Mar;116:154457. doi: 10.1016/j.metabol.2020.154457. Epub 2020 Dec 1.
7
Gut Dysbiosis and Increased Intestinal Permeability Drive microRNAs, NLRP-3 Inflammasome and Liver Fibrosis in a Nutritional Model of Non-Alcoholic Steatohepatitis in Adult Male Sprague Dawley Rats.肠道菌群失调和肠道通透性增加在成年雄性斯普拉格-道利大鼠非酒精性脂肪性肝炎营养模型中驱动微小RNA、NLRP-3炎性小体和肝纤维化
Clin Exp Gastroenterol. 2020 Sep 18;13:351-368. doi: 10.2147/CEG.S262879. eCollection 2020.
8
Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects.减重手术揭示了一种具有抗糖尿病作用的肠道受限 TGR5 激动剂。
Nat Chem Biol. 2021 Jan;17(1):20-29. doi: 10.1038/s41589-020-0604-z. Epub 2020 Aug 3.
9
Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor.微生物色氨酸代谢物通过芳香烃受体调节肠道屏障功能。
Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):19376-19387. doi: 10.1073/pnas.2000047117. Epub 2020 Jul 27.
10
Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.肠道微生物组和肠道屏障对肝脏疾病的贡献。
Gastroenterology. 2020 Sep;159(3):849-863. doi: 10.1053/j.gastro.2020.04.077. Epub 2020 Jun 20.